Episode Player
Bridging Pharma and Patients in Neuroendocrine Cancer Care
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
Bridging Pharma and Patients in Neuroendocrine Cancer Care
Apr 30, 2025
Season 4
Episode 2
🎙️ In this episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim.
Together, they explore:
- Common misconceptions about the pharmaceutical industry
- How patient organisations and the industry can work collaboratively
- How effective these collaborations can be
Tanya also highlights a current clinical trial led by Boehringer Ingelheim for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC). You can find more information about this trial here:
🔗 Boehringer Ingelheim – EP-NEC Clinical Trial
To learn more about ongoing neuroendocrine cancer research, visit our website:
🔗 Neuroendocrine Cancer UK – Research
